Both TP53 and RB1 mutations were present at trace levels (<1%) within region C. As clinical workup indicated that BI09 had an IDH1 mutation, we investigated all regions of this tumor by Sanger sequencing and found that regions A to E shared the IDH1 R132H mutation. Here, TP53 is linked to neoplasm.